NCT05076227View on ClinicalTrials.gov

Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity

CompletedOBSERVATIONAL

Enrollment

1,206

Participants

Timeline

Start Date

January 30, 2021

Primary Completion Date

March 27, 2022

Study Completion Date

March 27, 2022

Conditions

SARS-CoV2 InfectionImmunisation ReactionAntibody HypersensitivityTolerance

Interventions

DRUG

IM injection of vaccination (mRNA vaccination)

mRNA vaccination

DRUG

IM injection of vaccination (vector based vaccination)

vector based vaccination

Trial Locations (1)

31135

Helios Hospital Hildesheim, Hildesheim

All Listed Sponsors

lead

Serge Thal

OTHER

NCT05076227 - Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity | Biotech Hunter | Biotech Hunter